AstraZeneca gets DCGI nod for asthma drug ...Middle East

Drug firm AstraZeneca India on Tuesday said it has received marketing authorisation for an asthma drug from the Drugs Controller General of India (DCGI). The company has received approval from the DCGI for Fasenra (Benralizumab solution for injection in a single dose prefilled syringe30 mg/ml) for patients with severe asthma (eosinophilic asthma), AstraZeneca India said in a statement.

Hence then, the article about astrazeneca gets dcgi nod for asthma drug was published today ( Tuesday 22/12/2020 - 03:01 PM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca gets DCGI nod for asthma drug )

Also on site :

• Scared Hakeem Jeffries rolls out the red carpet for DSA extremists — while they prep to feast on his carcass
• Even Gavin Newsom knows his wealth-tax flip-flop won’t work
• Lefties couldn’t stop hating America even on its 250th anniversary